Ganaxolone, a selective, high-affinity steroid modulator of the γ- aminobutyric acid-A receptor, exacerbates seizures in animal models of absence

Annals of Neurology

Volumn 44, Issue 4, 1998, Pages 688-691

  Snead III, O Carter ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; GANAXOLONE; PENTETRAZOLE;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL MODEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; CONVULSANTS; EPILEPSY, ABSENCE; GABA ANTAGONISTS; HYDROXYBUTYRATES; MALE; PENTYLENETETRAZOLE; PREGNANOLONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 0031722019     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440417     Document Type: Article

References (21)

1. Kokate TG, Cohen AL, Karp E, Rogawski MA. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 1996;35:1049-1056
2. A receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992;38:370-395
3. 3H]flunitrazepam binding and γ-aminobutyric acidA receptor function. Mol Pharmacol 1994;46:977-985
4. A receptor. J Pharmacol Exp Ther 1997;280:1284-1295
5. A receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 1995;9:207-277
6. Snead OC. Basic mechanism of generalized absence seizures. Ann Neurol 1995;37:146-157
7. Bearden LJ, Snead OC, Healey CT, Pegram GV. Antagonism of γ-hydroxybutyric acid-induced frequency shifts in the cortical EEG of rats by dipropylacetate. Electroencephalogr Clin Neurophysiol 1980;49:181-183
8. Snead OC. The γ-hydroxyburyrate model of absence seizures: correlation of regional brain levels of γ-hydroxybutyric acid and γ-butyrolactone with spike wave discharges. Neuropharmacology 1991;30:161-167
9. Depaulis A, Snead OC, Marescaux C, Vergnes M. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 1989;498:64-72
10. Berkovic SF, Andermann F, Andermann E, Gloor P. Concepts of absence epilepsies: discrete syndromes or biologic continuum? Neurology 1987;37:993-1000
11. Gloor P, Fariello RG. Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci 1988;11:63-68
12. Snead OC. γ-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models. Epilepsia 1988;29:361-368
13. B-mediated mechanisms in experimental absence seizures. Eur J Pharmacol 1992;213:343-349
14. B and γ-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav 1996;53:73-79
15. B neurotransmission in the control of absence seizures in the rat. Neuroscience 1992;48:87-93
16. B receptor activation in absence seizures of lethargic (lh/lh) mice. Science 1992;257:398-401
17. Liu Z, Vergnes M, Depaulis A, Marescaux C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Res 1991;545:1-7
18. B-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J Physiol 1994;71:2576-2581
19. Banerjee PK, Snead OC. The neuroactive steroid, alphaxalone, facilitates absence-like seizures induced by γ-hydroxybutyric acid [GHB] in rats. Epilepsia 1997;28(Suppl 8):113 (Abstract)
20. Hosford DA, Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 1997;38:408-414
21. Snead OC, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985;313:916-921